XNYSOMI
Market cap1.11bUSD
Jan 08, Last price
14.41USD
1D
4.12%
1Q
7.06%
Jan 2017
-59.17%
Name
Owens & Minor Inc
Chart & Performance
Profile
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. It provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. The company was founded in 1882 and is headquartered in Richmond, Virginia.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 10,333,967 3.80% | 9,955,475 1.74% | |||||||
Cost of revenue | 10,024,623 | 9,774,592 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 309,344 | 180,883 | |||||||
NOPBT Margin | 2.99% | 1.82% | |||||||
Operating Taxes | (13,425) | (11,498) | |||||||
Tax Rate | |||||||||
NOPAT | 322,769 | 192,381 | |||||||
Net income | (41,301) -284.47% | 22,389 -89.90% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 204,082 | 79,336 | |||||||
Long-term debt | 2,335,456 | 2,913,906 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | 122,592 | 114,943 | |||||||
Net debt | 2,288,054 | 2,907,057 | |||||||
Cash flow | |||||||||
Cash from operating activities | 740,710 | 325,006 | |||||||
CAPEX | (190,870) | (166,582) | |||||||
Cash from investing activities | (137,254) | (1,804,476) | |||||||
Cash from financing activities | (417,330) | 1,497,105 | |||||||
FCF | 907,836 | 72,033 | |||||||
Balance | |||||||||
Cash | 243,037 | 69,467 | |||||||
Long term investments | 8,447 | 16,718 | |||||||
Excess cash | |||||||||
Stockholders' equity | 489,981 | 526,710 | |||||||
Invested Capital | 3,363,867 | 3,838,320 | |||||||
ROIC | 8.96% | 6.37% | |||||||
ROCE | 9.08% | 4.64% | |||||||
EV | |||||||||
Common stock shares outstanding | 75,785 | 76,217 | |||||||
Price | 19.27 -1.33% | 19.53 -55.10% | |||||||
Market cap | 1,460,377 -1.89% | 1,488,518 -54.67% | |||||||
EV | 3,748,431 | 4,395,575 | |||||||
EBITDA | 596,721 | 409,550 | |||||||
EV/EBITDA | 6.28 | 10.73 | |||||||
Interest | 157,915 | 128,891 | |||||||
Interest/NOPBT | 51.05% | 71.26% |